Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
NCT06859619 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183
Last updated 2025-03-05
Summary
Zoonoses and arboviroses refer to a group of diseases transmitted from animals to humans, either directly or indirectly (via mosquitoes, ticks or contact with contaminated environments). Most of these diseases are found in certain tropical zones, but global warming and increased international trade are modifying their geographical distribution, with a gradual trend towards temperate regions. A number of these pathogens have already been detected in Occitania, including dengue fever, West Nile, leishmaniasis and Q fever. Given the region's high mosquito population and favorable climatic conditions, other zoonoses have a strong potential to appear in the region, or may already be circulating at a low level. The study focuses on 18 pathogens selected for their potential to emerge and establish themselves in the Occitanie region: Leishmaniasis, Leptospirosis, Brucellosis, Q fever, Rickettsiosis, Tularemia, Psittacosis, Lyme disease, Tick-borne encephalitis, Hantavirus, Hepatitis E virus, Dengue virus, Zika virus, Chikungunya virus, West-Nile virus, Usutu virus, Toscana virus, Crimean-Congo haemorrhagic fever virus.
The aim of the study is to find out whether patients have antibodies against these infectious agents, which would indicate that they have been exposed to them in the past, even in the absence of symptoms.
Describing the circulation of these pathogens will enable to implement appropriate public health measures to avoid the risk of epidemics (mosquito control, informing professionals, etc.), as well as to assess the risk incurred in the workplace and have this risk recognized by the healthcare system.
Conditions
- Leishmaniasis
- Leptospirosis
- Brucellosis
- Q Fever
- Rickettsiosis
- Tularemia
- Psittacosis
- Lyme Disease
- Tick-borne Encephalitis
- Hantaviral Infection Nos
- Hepatitis E
- Dengue Virus
- Zika Virus
- Chikungunya Virus Infection
- West Nile Virus
- Usutu Virus
- Toscana Virus
- Crimean-Congo Haemorrhagic Fever Virus
Interventions
- OTHER
-
Peripheral venous blood sample
Peripheral venous blood sampling for IgG serology against leishmaniasis, leptospirosis, brucellosis, Q fever, rickettsiosis, tularemia, psittacosis, Lyme disease, tick-borne encephalitis, hantavirus, hepatitis E virus, dengue virus, Zika virus, Chikungunya virus, West Nile virus, Usutu virus, Toscana virus, Crimean-Congo hemorrhagic fever virus.
Sponsors & Collaborators
-
TransVIHMI UM, IRD UMI233, Inserm U1175
collaborator UNKNOWN -
UMR 1058 Pathogenesis & Control of Chronic & Emerging Infections PCCEI
collaborator UNKNOWN -
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
CHARLOTTE BOULLE, MD · University Hospital, Montpellier
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-03
- Primary Completion
- 2025-10-03
- Completion
- 2025-10-03
Countries
- France
Study Locations
More Related Trials
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
French West Indies Leptospirosis Study
NCT01607047 ·Status: UNKNOWN
-
Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean
NCT07119086 ·Status: RECRUITING ·Phase: NA
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
NCT03784248 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response
NCT05228639 ·Status: COMPLETED
-
Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
NCT04434846 ·Status: COMPLETED
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites
NCT01660854 ·Status: COMPLETED ·Phase: NA
-
Malaria Molecular Surveillance in Mozambique (Phase 2)
NCT06529237 ·Status: RECRUITING
-
Reproducibility of Malaria Challenge in Healthy Volunteers
NCT01058226 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
NCT04615364 ·Status: RECRUITING
-
Plasmodium Falciparum Genomic Intelligence in Mozambique
NCT05306067 ·Status: COMPLETED
-
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
NCT04034264 ·Status: RECRUITING
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
NCT02639299 ·Status: RECRUITING
-
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
NCT06268691 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
NCT04009824 ·Status: COMPLETED ·Phase: PHASE1
-
COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey
NCT04470648 ·Status: COMPLETED
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection
NCT02098590 ·Status: COMPLETED ·Phase: NA
-
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
NCT06064591 ·Status: COMPLETED
-
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
NCT03106714 ·Status: COMPLETED
-
Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali
NCT04710316 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine
NCT03055000 ·Status: COMPLETED ·Phase: PHASE1